/ PFE
/ Earnings
Pfizer Inc. (PFE) Beats Q2 Market Expectations with $13.3 Billion in Revenue
Pfizer Inc. reported a strong Q2 performance in 2024, with total revenues reaching $13.3 billion.
July 30, 2024
Stocks to Watch Today: Delta Air Lines, Tesla, and Pfizer
Major market movers today include Delta Air Lines tumbling on weak guidance, Tesla falling amid a debate over its stock performance, and Pfizer rising on development news.
July 11, 2024
Wall Street Weighs in as Pfizer Targets $100 Billion Weight Loss Market
Pfizer announced plans to advance a once-daily version of its weight loss pill, danuglipron, following encouraging early-stage trial results.
July 11, 2024
Pfizer (PFE) Reports Q1 Beat with $0.82 Adj. EPS, $14.9 Billion in Revenue
Pfizer Inc. reported a 20% decrease in total revenues for Q1 but beat expected EPS and revenue figures.
May 01, 2024
Pfizer (PFE) Q4 Results: $14.25B in Revenue and EPS of $0.1, Exceeding Forecasts
Pfizer reports Q4 2023 with strong financial results, achieving $14.25 billion in revenue and an EPS of $0.1.
January 30, 2024
Back to 
